Protara Therapeutics, Inc. (TARA)
3.95
-0.02
(-0.50%)
USD |
NASDAQ |
Sep 04, 16:00
3.95
0.00 (0.00%)
After-Hours: 19:32
Protara Therapeutics Cash and Short Term Investments (Annual) : 155.55M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 155.55M |
| December 31, 2024 | 170.29M |
| December 31, 2023 | 65.58M |
| December 31, 2022 | 84.37M |
| December 31, 2021 | 91.23M |
| December 31, 2020 | 168.65M |
| December 31, 2019 | 0.564M |
| Date | Value |
|---|---|
| December 31, 2018 | 21.87M |
| December 31, 2017 | 42.14M |
| December 31, 2016 | 41.32M |
| December 31, 2015 | 65.26M |
| December 31, 2014 | 83.60M |
| December 31, 2013 | 5.191M |
| December 31, 2012 | 7.51M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| NovelStem International Corp. | 0.0003M |
| Brainstorm Cell Therapeutics, Inc. | 0.029M |
| Summit Therapeutics, Inc. | 713.76M |
| Kezar Life Sciences, Inc. | 71.88M |
| Clene, Inc. | 5.189M |